New study affirms financial and public health advantages of treating drug-resistant TB with BPaL-Based Regimens in India

Researchers at the ICMR National Institute for Research in Tuberculosis conducted an economic evaluation study, focused on India, that compared seven short-course treatment regimens to the current standard of care (the 9-11 current standard of care). The outcomes of this study support that BPaL-based regimens both improve health outcomes and are cost-effective. This study supports efforts in shifting to approval of BPaL regimens for treating drug-resistant tuberculosis around the world. Read more here.